165 related articles for article (PubMed ID: 5774083)
41. Pharmacological fibrinolysis.
Fearnley GR
Bristol Med Chir J; 1969 Oct; 84(312):131-43. PubMed ID: 5824915
[No Abstract] [Full Text] [Related]
42. [Oral therapy of diabetes mellitus with sulfonylurea derivatives].
Schricker KT; Mpliatis A
Med Klin; 1970 Jun; 65(24):1163-6. PubMed ID: 5517342
[No Abstract] [Full Text] [Related]
43. [On the oral therapy of diabetes with oradian and chlorpropamide].
Kaeding A; Werner P
Dtsch Z Verdau Stoffwechselkr; 1967 Dec; 27(5):185-90. PubMed ID: 5595738
[No Abstract] [Full Text] [Related]
44. Status of problem of usage of tolbutamide. Preliminary statements.
Diabetes; 1970 Jun; 19(6):467-8. PubMed ID: 5467867
[No Abstract] [Full Text] [Related]
45. Tolanase - a sulphonylurea antidiabetic agent.
Drug Ther Bull; 1968 Mar; 6(7):27-8. PubMed ID: 5655488
[No Abstract] [Full Text] [Related]
46. [Increased risk of cardiovascular complications with oral hypoglycemic agents?].
Mueller R
Acta Diabetol Lat; 1970; 7(5):805-23. PubMed ID: 4949515
[No Abstract] [Full Text] [Related]
47. Adverse reactions to oral antidiabetic agents.
Harris EL
Br Med J; 1971 Jul; 3(5765):29-30. PubMed ID: 5091891
[No Abstract] [Full Text] [Related]
48. Effect of oral antidiabetic drugs on lipase activity in vitro.
Holmes JH; Sapeika N; Zwarenstein H
Res Commun Chem Pathol Pharmacol; 1975 Aug; 11(4):667-70. PubMed ID: 1179037
[TBL] [Abstract][Full Text] [Related]
49. Oral hypoglycemic compounds.
Bressler R
Adv Metab Disord; 1970; 1():Suppl 1:461+. PubMed ID: 5446913
[No Abstract] [Full Text] [Related]
50. Studies on the effect of oral hypoglycaemic agents on hepatic glycogenolysis.
Saleh S; Abdel-Khalek A; Khayyal MT; Masri AM; Sharat AA
Pharmacol Res Commun; 1974 Dec; 6(6):539-50. PubMed ID: 4376601
[No Abstract] [Full Text] [Related]
51. [Impact of intensive blood glucose control with hypoglycemic sulfamides, metformin or insulin on complications of non-insulin dependent diabetes].
André P
Rev Epidemiol Sante Publique; 1999 Mar; 47(1):93-5. PubMed ID: 10214683
[No Abstract] [Full Text] [Related]
52. ORAL HYPOGLYCEMIC DRUGS.
ARNOLD CR; LAUENER RW
Can Med Assoc J; 1964 Aug; 91(8):395-6. PubMed ID: 14179543
[No Abstract] [Full Text] [Related]
53. [Pharmacokinetics of blood glucose lowering biguanide derivatives].
Mehnert H
Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():137-42. PubMed ID: 4906018
[No Abstract] [Full Text] [Related]
54. [Side-effects of oral antidiabetic drugs].
Canaani Z
Harefuah; 1972 Apr; 82(7):334-6. PubMed ID: 4561190
[No Abstract] [Full Text] [Related]
55. ACETOHEXAMIDE: CLINICAL EVALUATION OF A NEW ORAL ANTIDIABETIC AGENT.
ALTERMAN SL; LIEBER AL
Curr Ther Res Clin Exp; 1964 Mar; 6():148-55. PubMed ID: 14131413
[No Abstract] [Full Text] [Related]
56. Oral hypoglycaemic agents.
Med J Aust; 1973 Mar; 1(12):570-1. PubMed ID: 4700542
[No Abstract] [Full Text] [Related]
57. Restraint in use of oral antidiabetic drugs.
N Engl J Med; 1967 Aug; 277(9):486. PubMed ID: 6032904
[No Abstract] [Full Text] [Related]
58. Clinical trial of a new sulphonylurea in maturity-onset diabetes--HB419 (glibenclamide).
Seftel HC
S Afr Med J; 1969 Aug; 43(32):979-80. PubMed ID: 4898091
[No Abstract] [Full Text] [Related]
59. Modification of response to the triamcinolone glucose tolerance test by treatment with oral hypoglycemic agents.
Navarrete VN; Torres IH; Castelazo Ayala L; Alger CR; Flores HV
Diabetes; 1966 Oct; 15(10):726-9. PubMed ID: 5332532
[No Abstract] [Full Text] [Related]
60. Clinical experience with acetohexamide an oral hypoglycemic, anti-diabetic agent.
Bergen SS
Pa Med; 1970 Aug; 73(8):49-52. PubMed ID: 4947380
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
